EUVIMEDEUVIMED entdecken
Crossref

Downregulation of lncRNA H19 Enhances Radiosensitivity in Colorectal Cancer by Inactivation of the ATR / CHK1 Signaling

Yuting Liang, Wanlu Zhang, Ao Dungerile, Juping Wang, Runmei Wang iD

APMIS · 2025

DOI: 10.1111/apm.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Yuting Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Inner Mongolia Medical University, Hohhot, Inner Mongolia, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Colorectal Neoplasms, Checkpoint Kinase 1, Ataxia Telangiectasia Mutated Proteins. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Inner Mongolia Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT) is commonly used in the treatment of colorectal cancer (CRC), but the resistance of cancer cells to radiation remains a significant challenge in clinical practice. This study aimed to investigate whether long non‐coding RNA (lncRNA) H19 could affect the sensitivity of CRC cells to radiation. The levels of H19 in CRC tissues and adjacent normal tissues, as well as in radioresistant and radiosensitive CRC tissues, were evaluated using RT‐qPCR. The levels of H19 were found to be higher in CRC tissues compared to adjacent normal tissues, as well as in radioresistant CRC tissues compared to radiosensitive tissues. Depletion of H19 intensified the anti‐tumor effects of radiation in CRC cells in vivo through further decreasing proliferation and enhancing apoptosis. In an HCT116 subcutaneous xenograft model, downregulation of H19 enhanced the anti‐tumor effect of radiation in CRC in vivo. Mechanistically, H19 was observed to interact with ATR. Meanwhile, H19 deficiency resulted in the suppression of ATR and CHK1 phosphorylation in CRC cells, suggesting that H19 knockdown could potentially impair DNA damage repair through ATR/CHK1 signaling. Collectively, downregulation of H19 could enhance the sensitivity of CRC cells to RT by impeding DNA damage repair through the inactivation of the ATR/CHK1 signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingColorectal NeoplasmsCheckpoint Kinase 1Ataxia Telangiectasia Mutated ProteinsRadiation ToleranceHumansSignal TransductionAnimalsDown-RegulationApoptosisMiceMice, NudeGene Expression Regulation, NeoplasticMaleCell ProliferationHCT116 CellsFemaleMice, Inbred BALB CCell Line, TumorXenograft Model Antitumor Assays

Stichwörter der Autor:innen

DNA damageRTcolorectal cancerlong non‐coding RNA H19radiosensitivity

Substanzen

RNA, Long NoncodingH19 long non-coding RNACheckpoint Kinase 1Ataxia Telangiectasia Mutated ProteinsCHEK1 protein, humanATR protein, human

Autor:innen und Institutionen

  • Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
  • Department of Radiotherapy Center, Inner Mongolia Medical University Affiliated Cancer Hospital, Hohhot, Inner Mongolia, China.

ORCID-Profile: Runmei Wang

Förderung

  • Natural Science Foundation of Inner Mongolia Autonomous Region

Zitieren

APA

Liang, Y., Zhang, W., Dungerile, A., Wang, J., & Wang, R. (2025). Downregulation of lncRNA H19 Enhances Radiosensitivity in Colorectal Cancer by Inactivation of the ATR / CHK1 Signaling. APMIS. https://doi.org/10.1111/apm.70052

Vancouver

Liang Y, Zhang W, Dungerile A, Wang J, Wang R. Downregulation of lncRNA H19 Enhances Radiosensitivity in Colorectal Cancer by Inactivation of the ATR / CHK1 Signaling. APMIS. 2025. doi:10.1111/apm.70052

BibTeX
@article{Liang2025,
  author = {Liang, Yuting and Zhang, Wanlu and Dungerile, Ao and Wang, Juping and Wang, Runmei},
  title = {Downregulation of lncRNA H19 Enhances Radiosensitivity in Colorectal Cancer by Inactivation of the ATR / CHK1 Signaling},
  journal = {APMIS},
  year = {2025},
  doi = {10.1111/apm.70052}
}
Kostenlos starten →